2023 Pediatric Rheumatology Symposium
$33500
PRYSM2023
Monday, April 17, 2023, 1:00 AM
Saturday, March 30, 2024, 11:55 PM
CME, MOC, ABP MOC, Participation
20.75
20.75
20.75

Activity Overview

The Pediatric Rheumatology Symposium (PRSYM) will provide up-to-date, practical clinical information and basic science knowledge on the diagnosis and management of pediatric patients with rheumatic diseases and immune disorders.

Key opinion leaders will deliver a range of content in areas such as therapeutic developments, recent research findings, and scientific advances, in an environment conducive to dialogue and networking.

Target Audience

Rheumatologists, physicians and other healthcare providers who care for pediatric patients with rheumatic diseases, clinical investigators, physician-scientists and those interested or engaged in research in the field of pediatric rheumatic diseases.

Learning Objectives

Upon completion of this activity, participants should be able to do the following: 

  1. Discuss the most up-to-date clinical information on the diagnosis and management of pediatric patients with rheumatic and immunologic disorders
  2. Describe the most current information regarding the pathophysiology underlying pediatric rheumatic disorders

CME Information

Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

See the ACR’s CME Mission Statement. For more information, download the AMA PRA Booklet.

Designation Statement
The ACR designates this live activity for a maximum of 20.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME credit must be claimed by March 30, 2024 at 11:59 PM ET.


MOC

MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.

After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.

American Board of Pediatrics' (ABP)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 20.75 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABP diplomates to the ABP diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABP Physician Portals. Please allow at least 48 hours for points to display in the portal.

MOC points must be claimed by March 30, 2024 at 11:59 PM ET.



Faculty & Disclosures

ACR Disclosure Statement

It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

Nature of Financial Relationships

Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience all financial relationships with ineligible companies any financial or other relationship(s) with an ineligible company including, but not limited to:

  1. Advisor or review panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/research support
  6. Speaker/honoraria includes speakers bureau, symposia, and expert witness
  7. Independent contractor
  8. Ownership interest
  9. Royalties
  10. Intellectual property/patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
  12. Other financial or material support

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

The PRSYM 2023 Planning Committee and faculty reported the following disclosures.

Disclosure Report

*All of the relevant financial relationships listed for these individuals have been mitigated.

+Corporate Support 

The ACR thanks Pfizer, Inc. for supporting the Pediatric Rheumatology Symposium with an independent medical education grant. 

Online Activity Refund Policy

  • Requests for cancellations and refunds must be received in writing to education@rheumatology.org within 24 hours of the online activity enrollment date.
  • Completed online activities are not eligible for a refund. 
  • Refunds will be subject to an administration fee per person and per activity: 15% for members; 30% for potential members.
  • Canceled online activities are nontransferable.

2023 Pediatric Rheumatology Symposium

The 2023 Pediatric Rheumatology Symposium is an in-person event with on-demand access.